FR2139505A5 - - Google Patents

Info

Publication number
FR2139505A5
FR2139505A5 FR7217130A FR7217130A FR2139505A5 FR 2139505 A5 FR2139505 A5 FR 2139505A5 FR 7217130 A FR7217130 A FR 7217130A FR 7217130 A FR7217130 A FR 7217130A FR 2139505 A5 FR2139505 A5 FR 2139505A5
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7217130A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syva Co
Original Assignee
Syva Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syva Co filed Critical Syva Co
Application granted granted Critical
Publication of FR2139505A5 publication Critical patent/FR2139505A5/fr
Priority to US05/649,942 priority Critical patent/US4039385A/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/946—CNS-stimulants, e.g. cocaine, amphetamines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR7217130A 1971-05-14 1972-05-12 Expired FR2139505A5 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US05/649,942 US4039385A (en) 1972-05-08 1976-01-19 Cardiac glycoside enzyme conjugates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14360971A 1971-05-14 1971-05-14

Publications (1)

Publication Number Publication Date
FR2139505A5 true FR2139505A5 (de) 1973-01-05

Family

ID=22504809

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7217130A Expired FR2139505A5 (de) 1971-05-14 1972-05-12

Country Status (12)

Country Link
JP (1) JPS5327763B1 (de)
BR (1) BR7202989D0 (de)
CA (1) CA1003770A (de)
CH (1) CH553410A (de)
DE (1) DE2223385C3 (de)
ES (1) ES402720A1 (de)
FR (1) FR2139505A5 (de)
GB (2) GB1401298A (de)
IL (1) IL39323A (de)
IT (1) IT972332B (de)
NL (1) NL170564C (de)
SE (1) SE403190B (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2301823A1 (fr) * 1975-02-20 1976-09-17 Syva Co Essai immunologique de determination d'une polyiodothyronine
FR2422165A1 (fr) * 1978-04-05 1979-11-02 Syva Co Procede et necessaire de dosage d'une substance immunologique par mesure de la lumiere fluorescente emise
WO1981001414A1 (en) * 1979-11-19 1981-05-28 Charles Hospital Dev An improved method of non homogenous enzyme immunoassay

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4104367A (en) * 1976-10-13 1978-08-01 Hoffmann-La Roche Inc. Radioimmunoassay for methadone
DE2923139A1 (de) * 1979-06-07 1980-12-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von immunologisch aktiven enzymmarkierten konjugaten
GB2120785A (en) * 1982-05-26 1983-12-07 Celltech Ltd Enzyme immunoassay
GB8407736D0 (en) * 1984-03-26 1984-05-02 Univ London Detecting specific polynucleotide sequences
IT1178788B (it) * 1984-12-21 1987-09-16 Sclavo Spa Metodo immunoenzimatico per la determinazione di analiti e composizione adatti allo scopo
US4833073A (en) * 1987-01-27 1989-05-23 Hoffmann-La Roche Inc. Immunoassay for tetrahydrocannabinol metabolites
US5374524A (en) * 1988-05-10 1994-12-20 E. I. Du Pont De Nemours And Company Solution sandwich hybridization, capture and detection of amplified nucleic acids
US5137804A (en) * 1988-05-10 1992-08-11 E. I. Du Pont De Nemours And Company Assay device and immunoassay
US5196306A (en) * 1989-03-29 1993-03-23 E. I. Du Pont De Nemours And Company Method for the detection or quantitation of an analyte using an analyte dependent enzyme activation system
EP2418492B1 (de) * 2010-08-10 2018-10-10 Randox Laboratories Ltd. Immunoreagens für Meprobamate

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2301823A1 (fr) * 1975-02-20 1976-09-17 Syva Co Essai immunologique de determination d'une polyiodothyronine
FR2422165A1 (fr) * 1978-04-05 1979-11-02 Syva Co Procede et necessaire de dosage d'une substance immunologique par mesure de la lumiere fluorescente emise
WO1981001414A1 (en) * 1979-11-19 1981-05-28 Charles Hospital Dev An improved method of non homogenous enzyme immunoassay

Also Published As

Publication number Publication date
IT972332B (it) 1974-05-20
ES402720A1 (es) 1976-12-01
DE2223385A1 (de) 1973-01-04
NL170564B (nl) 1982-06-16
NL7206434A (de) 1972-11-16
CH553410A (fr) 1974-08-30
IL39323A (en) 1975-08-31
GB1401297A (en) 1975-07-16
DE2223385C3 (de) 1984-10-25
IL39323A0 (en) 1972-06-28
BR7202989D0 (pt) 1973-11-01
DE2223385B2 (de) 1979-02-22
NL170564C (nl) 1982-11-16
GB1401298A (en) 1975-07-16
JPS5327763B1 (de) 1978-08-10
SE403190B (sv) 1978-07-31
CA1003770A (en) 1977-01-18

Similar Documents

Publication Publication Date Title
JPS5327763B1 (de)
AU2658571A (de)
AU2691671A (de)
AU3005371A (de)
AU2485671A (de)
AU2564071A (de)
AU2684071A (de)
AU2742671A (de)
AU2894671A (de)
AU2941471A (de)
AU2952271A (de)
AU2724971A (de)
AU2836771A (de)
AU3038671A (de)
AU3025871A (de)
AU2706571A (de)
AU2963771A (de)
AU2503871A (de)
AU2577671A (de)
AU2940971A (de)
AU2938071A (de)
AU2930871A (de)
AU2927871A (de)
AU2907471A (de)
AU2588771A (de)